High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. Behrens S, Potter K, Patel RK, Schwantes IR, et al. Am J Surg 2023 Feb 21:S0002-9610(23)00063-6. doi: 10.1016/j.amjsurg.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Behrens S, Potter K, Patel RK, Schwantes IR, et al. High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. Am J Surg 2023 Feb 21:S0002-9610(23)00063-6. doi: 10.1016/j.amjsurg.2023.
PMID: 36858864